Compare TERN & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TERN | ENPH |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 5.8B |
| IPO Year | 2021 | 2012 |
| Metric | TERN | ENPH |
|---|---|---|
| Price | $37.50 | $43.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 24 |
| Target Price | ★ $48.60 | $42.89 |
| AVG Volume (30 Days) | 1.9M | ★ 9.7M |
| Earning Date | 03-19-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.77 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,472,985,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.36 |
| P/E Ratio | ★ N/A | $33.71 |
| Revenue Growth | N/A | ★ 10.72 |
| 52 Week Low | $1.87 | $25.78 |
| 52 Week High | $48.26 | $70.78 |
| Indicator | TERN | ENPH |
|---|---|---|
| Relative Strength Index (RSI) | 55.99 | 54.75 |
| Support Level | $37.02 | $47.07 |
| Resistance Level | $39.60 | $52.24 |
| Average True Range (ATR) | 2.15 | 3.29 |
| MACD | 0.26 | 0.09 |
| Stochastic Oscillator | 78.75 | 47.88 |
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.